Onward Medical NV ONWD

AMS: ONWD | ISIN: NL0015000HT4   30/04/2025
4,190 EUR (+1,21%)
(+1,21%)   30/04/2025

30 april 2025 · ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions · Persbericht

28 april 2025 · ONWARD Medical Announces Release of 2024 Annual Report · Persbericht

24 april 2025 · ONWARD Medical Establishes US ADR Program and Begins Trading on OTCQX Best Market · Persbericht

1 april 2025 · ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights · Persbericht

1 april 2025 · ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025 · Persbericht

26 maart 2025 · ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility · Persbericht

19 maart 2025 · ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast · Persbericht

4 maart 2025 · ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense · Persbericht

25 februari 2025 · ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy · Persbericht

29 januari 2025 · ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms · Persbericht

13 januari 2025 · ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference · Persbericht

9 januari 2025 · ONWARD Medical Announces First Commercial Sales of ARC-EX System · Persbericht

19 december 2024 · ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury · Persbericht

19 december 2024 · ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de la moelle épinière · Persbericht

12 december 2024 · ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability · Persbericht

26 november 2024 · ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights · Persbericht

19 november 2024 · ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke · Persbericht

12 november 2024 · ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights · Persbericht

31 oktober 2024 · ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024 · Persbericht

28 oktober 2024 · ONWARD® Medical Publishes Closing of Bookbuild Offering · Persbericht

Mijn selecties